(113 days)
The Metron QA-IDS Infusion Pump Tester is designed for use by trained service technicians, for testing all types of infusion purips. Tests include volumetric tests, and occlusion tests. The Metron-QA-IDS Infusion:Putmp;Tester is designed to be used by trained service technicians.
Not Found
This document is a 510(k) clearance letter from the FDA for a device called "Metron QA-IDS I.V. Pump Tester." It does not contain the kind of detailed study information (acceptance criteria, performance data, sample sizes, ground truth, etc.) that you are asking for. It's a regulatory approval document confirming that the device is substantially equivalent to legally marketed predicate devices.
Therefore, I cannot extract the requested information from the provided text. The document is for a medical device that tests infusion pumps, not an AI or diagnostic device that would typically have the kind of performance metrics you've listed.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling a stylized caduceus or a representation of the human form, composed of three curved lines.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP 3 0 1998
Metron U.S., Incorporated C/O Mr. E.J. Smith Smith Associates P.O. Box 4341 Crofton, Maryland 21114-4341
Re : K982020 Trade Name: Metron QA-IDS I.V. Pump Tester Regulatory Class: II Product Code: FRN Dated: September 16, 1998 September 16, 1998 Received:
Dear Mr. Smith:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. ਸੇ substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
{1}------------------------------------------------
Page 2 - Mr. Smith
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4692. Additionally, for questions on the promotion and advertising of your device, please contact. the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html an
Sincerely yours, univ
Timothy A. Ulatowski Director
Division of Dental, Infection Control, and General Hospital Devices
Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
510(k) Number (if known): K982020
Device Name: QA-IDS I.V. Tester
Classification Panel: FRN 21 CFR 880.5725
Indications for Use:
The Metron QA-IDS Infusion Pump Tester is designed for use by trained service technicians, for testing all types of infusion purips. Tests include volumetric tests, and occlusion tests.
The Metron-QA-IDS Infusion:Putmp;Tester is designed to be used by trained service technicians.
(PLEASE DO NOT WRITE BELOW THIS LINE- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE) Over-the-Counter Use Prescription Use_ or
Pastacea Cucenta
(Division Sign-Off)
Division of Dental, Infection Control, and General Hospital, Infrection of
510(k) Number ________________________________________________________________________________________________________________________________________________________________
§ 880.5725 Infusion pump.
(a)
Identification. An infusion pump is a device used in a health care facility to pump fluids into a patient in a controlled manner. The device may use a piston pump, a roller pump, or a peristaltic pump and may be powered electrically or mechanically. The device may also operate using a constant force to propel the fluid through a narrow tube which determines the flow rate. The device may include means to detect a fault condition, such as air in, or blockage of, the infusion line and to activate an alarm.(b)
Classification. Class II (performance standards).